acyl-enzyme after reaction with the active site serine hy-
droxyl as shown in Scheme 1.5
cephalosporin. The commercially available7 3-hydroxy-
cephem 6 seemed a promising precursor for the generation
of such materials. Reasoning that it was probably not possible
to subject a reactive C3 triflate to the reaction conditions
needed to prepare the appropriate C7 alkylidene analogues,
we initially attempted to use O-protected derivatives. How-
ever, we found that such intermediates were prone to double
bond isomerization (i.e., migration of the double bond from
the ∆-3,4 position to the ∆-2,3 position), and we settled on
the 3-halocephalosporin sulfones as potential alternatives.
Our synthesis of key precursors 11 and 12 is shown in
Scheme 3.
Scheme 1. Mechanistic Pathway Leading to a Stabilized Acyl
Enzyme Intermediate
Scheme 3. New Synthetic Route Employing
3-Halo-7-alkylidenecephem Sulfonesa
In the process of preparing these new inhibitors, it became
necessary for us to devise methodology for the synthesis of
C3 functionalized cephalosporins. In particular, we desired
a method for the preparation of a structurally diverse
collection of side chains from an appropriate late-stage C3-
substituted synthetic precursor. As shown in Scheme 2, we
a Reagents: (i) Tf2O, DIPEA, DCM -78 °C, 85%; (ii) LiBr or
LiI (2.5 equiv), THF, rt 36 h, 88% or 72%; (iii) PCl5, py, DCM/
MeOH, 0 °C, 74%; (iv) i-prONO, cat. TFA, EtOAc; (v) propylene
oxide, cat. Rh2(OOct)4, C6H6; (vi) R-py-CH2-PPh3Cl, KO-t-Bu,
THF/DCM (30% overall for steps iv, v, and vi); (vii) MCPBA (2.5
equiv), DCM, rt, 30 min, 90%; (viii) R′3SnR, cat. Pd2(dba)3, DMF
or THF (see Table 1).
Scheme 2. Previous Route to 3-Substituted
7-Alkylidenecephem Sulfones
Thus the enol 6 was readily converted to the corresponding
triflate using triflic anhydride in the presence of Hunig’s base.
Subsequent treatment of the triflate with anhydrous LiX in
dry THF produced the corresponding vinyl halides in good
yield. Removal of the phenylacetyl group using PCl5
produced the corresponding amines 7 and 8, which were then
converted to the 7-oxocephalosporins 9 and 10, respectively,
using our reported procedure.8 These ketones were then used
directly in the following Wittig reaction, and the alkylidene
products were selectively oxidized to the corresponding
sulfones 11 and 12.
As demonstrated in Table 1, the vinyl iodide 12, in
particular, was an excellent precursor to a number of
(previously unavailable) C3-functionalized 7-(Z-pyridyl-
methylidene)cephalosporin sulfones, 13. As shown by entry
4, we were able to prepare the benzhydryl ester of the 3′Z
stereoisomer of our highly potent inhibitor 2 from the 3Z-
had earlier reported a route to such compounds employing
aldehyde 5.4d However, the suitability of this earlier route
to the preparation of libraries of inhibitors is limited by both
the unexpectedly low reactivity of aldehyde 5 and the need
for the use of a separate Wittig reagent in the preparation of
each new inhibitor.
Farina had earlier reported the synthesis of substituted
cephalosporins through a versatile Stille-coupling of the
3-position cephalosporin triflates with organostannanes.6
Effective utilization of such a catalytic coupling in the
generation of new â-lactamase inhibitors in this series of
molecules would require an appropriately C3 functionalized
(5) a) Crichlow, G. V.; Nukaga, M.; Buynak, J. D.; Knox, J. R.
Biochemistry 2001, 40, 6233-6239. (b) Strynadka, N.; Buynak, J. D.
Unpublished results.
(7) Otsuka Chemical Co.
(6) Farina, V.; Baker, S.; Sapino, C. Tetrahedron Lett. 1988, 29, 6043-
6046. (b) Farina, V.; Baker, S. R.; Hauck, S. I. J. Org. Chem. 1989, 54,
4962-4966.
(8) Buynak, J. D.; Rao, A. S.; Nidamarthy, S. D. Tetrahedron Lett. 1998,
39, 4945-4946. Ketones 9 and 10 are not purified because of their
instability.
2954
Org. Lett., Vol. 3, No. 19, 2001